Dunni Niyi Odumosu

Dunni Odumosu, MS, is a seasoned professional in regulatory affairs and sciences, currently serving as Vice President of Global Regulatory Affairs & Sciences for Gene Therapy at BridgeBio since October 2019. Previously, Dunni held key roles at Amicus Therapeutics, where responsibilities included leading global regulatory strategies for Fabry Disease and managing regulatory submissions. Prior experience also includes positions at Arewa Cosmetics, PharmaLex US, and L'Oréal, where Dunni contributed to regulatory document preparation, management of clinical trials, and collaboration on project development. Dunni holds a Bachelor of Science in Chemistry and a Master of Science in Quality Assurance/Regulatory Affairs from Temple University.